Dr Reddy's Laboratories witnessed a rise in share price on Wednesday after the company said that it has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration on June 13, 2017 after closure of audit for the company's API manufacturing plant at Miryalaguda.

This unit was inspected by the USFDA in February 2017 and DRL was issued form 483 with three observations. 

Shares of Dr Reddy'S Laboratories are trading at Rs 2,696.95, up Rs 68.85, or 2.62% at the Bombay Stock Exchange (BSE) on Wednesday at 10:19 a.m.

The scrip has touched an intra-day high of Rs 2,698 and low of Rs 2,647. The total volume of shares traded at the BSE is 28,601.

Total volume of shares traded on the bourses today was lower by 42.60% to 288,777 compared with 22-day average volume of 503,120.